Doctors Only Bulletin Board System (DOBBS)

Forums => Medical News (Public) => Topic started by: Ketua Dobbs on January 17, 2025, 08:57:32 PM

Title: Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency
Post by: Ketua Dobbs on January 17, 2025, 08:57:32 PM

Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency

Researchers report the ability of tofacitinib to reduce infection risk with SARS-CoV-2 in individuals who are deficient in PTPN2.
Source: Tofacitinib reduces SARS-CoV-2 infection risk in patients with PTPN2 deficiency (https://www.news-medical.net/news/20250117/Tofacitinib-reduces-SARS-CoV-2-infection-risk-in-patients-with-PTPN2-deficiency.aspx)